Background: Corona virus-19 disease (COVID-19) marked the beginning of a new pandemic COVID-19 after massive numbers of acute pneumonia with unknown origin.Some COVID-19 confirmed patients experienced some skin lesions that might be a clinical sign of COVID-19.Objective: This study aimed to determine the diversity of skin lesions caused by COVID-19 in Elbagour Hospital admitted COVID-19 positive cases.Methods: A prospective cohort study included patients from both sex who were COVID-19 confirmed and experienced skin lesions.1020 patients having COVID-19 were examined.Out of them, 600 cases showed skin lesions.They were evaluated in El-Bagour General Hospital during the isolation period from March 2020 to March 2021.Dermatological examinations were done to assess skin lesions.The ABCD score was used to determine the severity of COVID-19 patients. Results:We reported eight types of skin lesions in the form of pityriasis rosea like lesions (387; 63%), vesicular like exanthema (320; 53.3%), erythema multiform (298; 49.7%), petechiae (232; 38.7%), urticarial lesions (231; 38.5%), maculo-papules (220; 36.7%),livedo reticularis (84; 14%) and pseudo-chilblain (74; 12.3%).Presence of skin lesions were significantly associated with moderate and severe cases (p < 0.05).Livedo reticularis was significantly linked to a high mortality rate (p < 0.001).Conclusion: Presence of skin lesions, as well as their number, onset and type were associated with COVID-19 prognosis.Presence of early (within the first 4 days) and more than 2 skin lesion types denoted disease severity.Moreover, livedo reticularis and maculo-papules warn against more disease severity, while presence of pseudo-chilblain points to moderate disease.